Delivery Order SPE2DR25D1100-SPE2DR26FCV0S
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,337.12 to AmerisourceBergen Drug Corp for 100 capsules of dextroamphetamine-amphetamine 20 mg. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by December 16, 2025. The order is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor serving...
- The Defense Logistics Agency awarded a $1,531.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 capsules of Dextroamphetamine-Amphetamine 20 mg on December 15, 2025, with completion scheduled for December 16, 2025. The award was made without a set-aside designation through open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a $1,488.80 delivery order to AmerisourceBergen Drug Corp for 100 capsules of Dextroamphetamine-Amphetamine 20 mg on May 23, 2025, with an ultimate completion date of May 27, 2025. This firm fixed-price delivery order is non-set-aside and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal...
- The Defense Logistics Agency awarded a delivery order valued at $3,009.48 to AmerisourceBergen Drug Corp for 100 capsules of Dextroamphetamine-Amphetamine 20 mg, with an ultimate completion date of December 16, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed price pricing and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen is a major pharmaceutical distributor and critical federal medical procurement vendor...
- The Defense Logistics Agency awarded a delivery order valued at $2,220.67 to AmerisourceBergen Drug Corp for 100 capsules of Dextroamphetamine-Amphetamine 30 mg on September 19, 2025, with an ultimate completion date of September 22, 2025. This firm fixed-price, non-set-aside delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a small-value pharmaceutical procurement supporting federal medical supply needs...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,870.99 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 20 mg capsules (100-count units) on September 16, 2025, with an ultimate completion date of September 17, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,548.09 to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Dextroamphetamine-Amphetamine 20 mg capsules (100-count units). This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of August 12, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a $1,148.89 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 capsules of Dextroamphetamine-Amphetamine 30 mg, with a completion date of September 12, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical supply will be delivered...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for 100 capsules of Dextroamphetamine-Amphetamine 25 mg, valued at $1,169.78. The award was made on July 31, 2025, with an ultimate completion date of August 1, 2025. This non-set-aside, competitively awarded delivery order employs firm fixed-price pricing and represents a direct fulfillment of pharmaceutical supply needs for federal military healthcare operations....
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,062.60 for 100 capsules of Dextroamphetamine-Amphetamine 20 mg on April 24, 2025, with an ultimate completion date of April 25, 2025. This competitively awarded, firm fixed-price contract requires performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order was issued without a set-aside designation, reflecting open competition among qualified pharmaceutical...
- SPE2DR25D1100Indefinite Delivery Contract
- SPE2DR25D1100-SPE2DR26FCV0SDelivery Order
The Defense Logistics Agency (DLA) awarded a $2,487.10 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 capsules of Dextroamphetamine-Amphetamine 20 mg, with a completion date of December 17, 2025. This non-set-aside delivery order represents a small-value pharmaceutical procurement supporting the federal medical supply chain. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for military and veteran healthcare systems through the DLA. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00 ceiling value and extends through December 2026. This comprehensive global pharmaceutical support vehicle enables the contractor to supply a wide range of pharmaceutical products, including specialty medications, brand-name and generic drugs, and medical supplies to support military healthcare programs worldwide. The delivery order falls within the broader context of DLA's pharmaceutical procurement operations, which serve the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 12/15/25 |